MedPath

AURO-LAMOTRIGINE

AURO-LAMOTRIGINE

Approved
DIN Number

02381354

Drug Class

Human

Market Date

Jun 13, 2012

Company
HC

auro pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02381354
AIG Number0127134003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AX09 LAMOTRIGINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

LAMOTRIGINEActive
Strength: 25 MG
Monograph: LAMOTRIGINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.